These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

117 related items for PubMed ID: 7966138

  • 1. 5-Phenyl-3-ureidobenzazepin-2-ones as cholecystokinin-B receptor antagonists.
    Lowe JA, Hageman DL, Drozda SE, McLean S, Bryce DK, Crawford RT, Zorn S, Morrone J, Bordner J.
    J Med Chem; 1994 Oct 28; 37(22):3789-811. PubMed ID: 7966138
    [Abstract] [Full Text] [Related]

  • 2. Synthesis and pharmacological properties of ureidomethylcarbamoylphenylketone derivatives. A new potent and subtype-selective nonpeptide CCK-B/gastrin receptor antagonist, S-0509.
    Hagishita S, Murakami Y, Seno K, Kamata S, Haga N, Konoike T, Kanda Y, Kiyama R, Shiota T, Ishihara Y, Ishikawa M, Shimamura M, Abe K, Yoshimura K.
    Bioorg Med Chem; 1997 Aug 28; 5(8):1695-714. PubMed ID: 9313871
    [Abstract] [Full Text] [Related]

  • 3. Biological properties of the benzodiazepine amidine derivative L-740,093, a cholecystokinin-B/gastrin receptor antagonist with high affinity in vitro and high potency in vivo.
    Patel S, Smith AJ, Chapman KL, Fletcher AE, Kemp JA, Marshall GR, Hargreaves RJ, Ryecroft W, Iversen LL, Iversen SD.
    Mol Pharmacol; 1994 Nov 28; 46(5):943-8. PubMed ID: 7969084
    [Abstract] [Full Text] [Related]

  • 4. Role of N- and C-terminal substituents on the CCK-B agonist-antagonist pharmacological profile of Boc-Trp-Phg-Asp-Nal-NH2 derivatives.
    Weng JH, Blommaert AG, Moizo L, Bado A, Ducos B, Böhme A, Garbay C, Roques BP.
    Bioorg Med Chem; 1996 Apr 28; 4(4):563-73. PubMed ID: 8735845
    [Abstract] [Full Text] [Related]

  • 5. Synthesis and SAR of new 5-phenyl-3-ureido-1,5-benzodiazepines as cholecystokinin-B receptor antagonists.
    Ursini A, Capelli AM, Carr RA, Cassarà P, Corsi M, Curcuruto O, Curotto G, Dal Cin M, Davalli S, Donati D, Feriani A, Finch H, Finizia G, Gaviraghi G, Marien M, Pentassuglia G, Polinelli S, Ratti E, Reggiani AM, Tarzia G, Tedesco G, Tranquillini ME, Trist DG, Van Amsterdam FT.
    J Med Chem; 2000 Oct 05; 43(20):3596-613. PubMed ID: 11020274
    [Abstract] [Full Text] [Related]

  • 6. New 1,4-benzodiazepin-2-one derivatives as gastrin/cholecystokinin-B antagonists.
    Satoh M, Kondoh Y, Okamoto Y, Nishida A, Miyata K, Ohta M, Mase T, Murase K.
    Chem Pharm Bull (Tokyo); 1995 Dec 05; 43(12):2159-67. PubMed ID: 8582018
    [Abstract] [Full Text] [Related]

  • 7. Synthesis of phenoxyacetic acid derivatives as highly potent antagonists of gastrin/cholecystokinin-B receptors. II.
    Takeda Y, Kawagoe K, Yokomizo A, Yokomizo Y, Hosokami T, Shimoto Y, Tabuchi Y, Ogihara Y, Otsubo R, Honda Y, Yokohama S.
    Chem Pharm Bull (Tokyo); 1998 Jun 05; 46(6):951-61. PubMed ID: 9658573
    [Abstract] [Full Text] [Related]

  • 8. (3R)-N-(1-(tert-butylcarbonylmethyl)-2,3-dihydro-2-oxo-5-(2-pyridyl)-1H-1,4-benzodiazepin-3-yl)-N'-(3-(methylamino)phenyl)urea (YF476): a potent and orally active gastrin/CCK-B antagonist.
    Semple G, Ryder H, Rooker DP, Batt AR, Kendrick DA, Szelke M, Ohta M, Satoh M, Nishida A, Akuzawa S, Miyata K.
    J Med Chem; 1997 Jan 31; 40(3):331-41. PubMed ID: 9022799
    [Abstract] [Full Text] [Related]

  • 9. Pharmacological profile of (R)-1-[2,3-dihydro-1-(2'-methylphenacyl)-2-oxo- 5-phenyl-1H-1,4-benzodiazepin-3-yl]-3-(3-methylphenyl)urea (YM022), a new potent and selective gastrin/cholecystokinin-B receptor antagonist, in vitro and in vivo.
    Nishida A, Miyata K, Tsutsumi R, Yuki H, Akuzawa S, Kobayashi A, Kamato T, Ito H, Yamano M, Katuyama Y.
    J Pharmacol Exp Ther; 1994 May 31; 269(2):725-31. PubMed ID: 7910212
    [Abstract] [Full Text] [Related]

  • 10. Pharmacological properties of ureido-acetamides, new potent and selective non-peptide CCKB/gastrin receptor antagonists.
    Bertrand P, Böhme GA, Durieux C, Guyon C, Capet M, Jeantaud B, Boudeau P, Ducos B, Pendley CE, Martin GE.
    Eur J Pharmacol; 1994 Sep 12; 262(3):233-45. PubMed ID: 7813588
    [Abstract] [Full Text] [Related]

  • 11. Cholecystokinin B antagonists. Synthesis and quantitative structure-activity relationships of a series of C-terminal analogues of CI-988.
    Augelli-Szafran CE, Horwell DC, Kneen C, Ortwine DF, Pritchard MC, Purchase TS, Roth BD, Trivedi BK, Hill D, Suman-Chauhan N, Webdale L.
    Bioorg Med Chem; 1996 Oct 12; 4(10):1733-45. PubMed ID: 8931944
    [Abstract] [Full Text] [Related]

  • 12. Biological activity of analogues of YM022. Novel (3-amino substituted phenyl)urea derivatives of 1,4-benzodiazepin-2-one as gastrin/cholecystokinin-B receptor antagonists.
    Satoh M, Okamoto Y, Koshio H, Ohta M, Nishida A, Akuzawa S, Miyata K, Mase T, Semple G.
    Chem Pharm Bull (Tokyo); 1996 Jul 12; 44(7):1412-4. PubMed ID: 8706146
    [Abstract] [Full Text] [Related]

  • 13. Potent and subtype-selective CCK-B/gastrin receptor antagonists: 2,4-dioxo-1,5-benzodiazepines with a plane of symmetry.
    Hagishita S, Seno K, Kamata S, Haga N, Ishihara Y, Ishikawa M, Shimamura M.
    Bioorg Med Chem; 1997 Jul 12; 5(7):1433-46. PubMed ID: 9377103
    [Abstract] [Full Text] [Related]

  • 14. Selective non-peptide ligands for an accommodating peptide receptor. Imidazobenzodiazepines as potent cholecystokinin type B receptor antagonists.
    Bock MG, DiPardo RM, Newton RC, Bergman JM, Veber DF, Freedman SB, Smith AJ, Chapman KL, Patel S, Kemp JA.
    Bioorg Med Chem; 1994 Sep 12; 2(9):987-98. PubMed ID: 7712133
    [Abstract] [Full Text] [Related]

  • 15. Characterization of antisecretory and antiulcer activity of CR 2945, a new potent and selective gastrin/CCK(B) receptor antagonist.
    Makovec F, Revel L, Letari O, Mennuni L, Impicciatore M.
    Eur J Pharmacol; 1999 Mar 12; 369(1):81-90. PubMed ID: 10204685
    [Abstract] [Full Text] [Related]

  • 16. Synthesis of phenoxyacetic acid derivatives as highly potent antagonists of gastrin/cholecystokinin-B receptors. III.
    Takeda Y, Kawagoe K, Yokomizo A, Yokomizo Y, Hosokami T, Shimoto Y, Tabuchi Y, Ogihara Y, Honda Y, Kawarabayashi K, Iseri M, Yokohama S.
    Chem Pharm Bull (Tokyo); 1999 Jun 12; 47(6):755-71. PubMed ID: 10399834
    [Abstract] [Full Text] [Related]

  • 17. A new potent and selective non-peptide gastrin antagonist and brain cholecystokinin receptor (CCK-B) ligand: L-365,260.
    Lotti VJ, Chang RS.
    Eur J Pharmacol; 1989 Mar 21; 162(2):273-80. PubMed ID: 2721567
    [Abstract] [Full Text] [Related]

  • 18. Dual CCK-A and CCK-B receptor antagonists (II). Preparation and structure activity relationships of 5-alkyl-9-methyl-1,4-benzodiazepines and discovery of FR208419.
    Tabuchi S, Ito H, Sogabe H, Kuno M, Kinoshita T, Katumi I, Yamamoto N, Mitsui H, Satoh Y.
    Chem Pharm Bull (Tokyo); 2000 Jan 21; 48(1):1-15. PubMed ID: 10705468
    [Abstract] [Full Text] [Related]

  • 19. Functional comparisons of gastrin/cholecystokinin receptors in isolated preparations of gastric mucosa and ileum.
    Patel M, Spraggs CF.
    Br J Pharmacol; 1992 Jun 21; 106(2):275-82. PubMed ID: 1393262
    [Abstract] [Full Text] [Related]

  • 20. Development of peptide 3D structure mimetics: rational design of novel peptoid cholecystokinin receptor antagonists.
    Low CM, Black JW, Broughton HB, Buck IM, Davies JM, Dunstone DJ, Hull RA, Kalindjian SB, McDonald IM, Pether MJ, Shankley NP, Steel KI.
    J Med Chem; 2000 Sep 21; 43(19):3505-17. PubMed ID: 11000005
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.